My first contact with pharmaceutical patents was in my childhood, when I had no idea what law was. My father, who worked in a pharmaceutical company, often mentioned news from the pharmaceutical world at home. This was one of the reasons why I decided to focus more on intellectual property during my law studies. The second reason was that during the Erasmus programme in Lisbon, we could only choose between English courses focused on intellectual property or other courses in Portuguese. And so I had no choice but to choose intellectual property. To my surprise at the time, new technologies became my passion and I have been pursuing them ever since. In addition to intellectual property and ICT law, I also like to deal with personal data protection and contractual firstname.lastname@example.org
Contributed to articles
What are the changes brought about by the forthcoming design protection reform in Europe?
The European Commission has submitted to the European Parliament and the Council proposals to reform both the EU and national design protection legislation. The proposals submitted by the European Commission aim to modernise the current European legal framework for designs and increase the harmonisa